[Ten years of advances in head and neck surgery, how does this influence postoperative radiotherapy?]

Abstract:

:Minimal invasive surgery and reconstructive surgery tend to become the standard in France in the management of head and neck tumors. The use of endoscopic approaches (through endoscopic endonasal/transoral approaches±robot-assisted) instead of open surgery and the use of reconstructive surgery using autologous (flaps) or heterologous materials aim to reduce surgical morbidity by making-up for the loss of substance to restore the function. The impact of these substantial changes in surgical techniques has not been assessed with respect to postoperative radiotherapy practice. Endoscopic endonasal approaches result, however, in piecemeal resection, which, along the analysis of resection margins (a key prognostic factor), make the interpretation of the quality of resection more complex for radiation oncologists. The definition of tumour sub-volumes to be irradiated and doses to these sub-volumes then requires accurate histosurgical mapping and close multidisciplinary consultation between surgeons, pathologists, radiologists and radiation oncologists. Similarly, the increasing use of various types of flaps (of soft tissue or bone flaps), adapted to the patient and tumor anatomy, is associated with substantial modifications to the operating bed. The delineation of tumour volumes in postoperative radiotherapy is made more complex. Tremendous multidisciplinary efforts should now be initiated to fully take advantage of surgical advances and to further optimize the therapeutic index by making radiotherapy also less toxic, i.e. "mini-morbid".

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Thariat J,Leleu T,Micault E,Gery B,Bastit V,Jeanne C,Humbert M,Dugas A,Le Guevelou J,Florescu C,Patron V,Lasne-Cardon A,Babin E

doi

10.1016/j.bulcan.2020.04.011

subject

Has Abstract

pub_date

2020-01-01 00:00:00

pages

823-829

issue

7-8

eissn

0007-4551

issn

1769-6917

pii

S0007-4551(20)30228-9

journal_volume

107

pub_type

杂志文章,评审
  • [Postmastectomy pain syndrome evidence based guidelines and decision trees].

    abstract::A multidisciplinary expert group had reviewed all scientific data available of post mastectomy pain syndrome. Seventy six publications were retained and thirty evidence based diagnosis, treatment and follow-up recommendations are listed. Few of theses recommendations are classed level A. Datas analysis make possible t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引,评审

    doi:

    authors: Labrèze L,Dixmérias-Iskandar F,Monnin D,Bussières E,Delahaye E,Bernard D,Lakdja F

    更新日期:2007-03-01 00:00:00

  • [Prevalence of cancer, health care and daily life assistance in people aged 75 or over living in the Tarn area (France)].

    abstract::The association between cancer and dependence was estimated using a cross-sectional study among persons 75 years of age or-older in Tarn county (area with a cancer registry recognized by the National Committee of Registries). A representative random sample stratified on age, sex, and size of district, was drawn using ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Faliu B,Berthier F,Grosclaude P,Aptel I,Cayla F,Machelard-Roumagnac M,Duchene Y

    更新日期:1997-02-01 00:00:00

  • [Imatinib in the treatment of chronic myeloid leukemia in Morocco].

    abstract:INTRODUCTION:The treatment of chronic myeloid leukemia (CML) has been revolutionized by the advent of tyrosine kinase inhibitors. The results of the IRIS trial demonstrated the efficacy and long-term safety profile of Imatinib. The objective of our work is to report the results at 15 years of treatment of CML in chroni...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.05.013

    authors: Dakkoune M,Qachouh M,Zoukal S,Hassoune S,Khoubila N,Cherkaoui S,Lamchahab M,Rachid M,Madani A,Quessar A

    更新日期:2020-09-01 00:00:00

  • [Medico-economical assessment in cancerology].

    abstract::In recent studies, the economic criteria has begun to be integrated to the appraisal in cancerology. The question asked by the economist can be framed as follows: what incremental cost should the collectivity or the health insurance system consent, in order to improve the care of cancer patients? This involves first t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lebrun T,Selke B,Bercez C,Bonneterre ME,Lenne X,Sailly JC,Bonneterre J

    更新日期:1997-05-01 00:00:00

  • [Not Available].

    abstract::THE ROLE OF RUXOLITINIB IN THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS: The discovery of the JAK2V617F mutation in 2005, present in 95% of polycythemia vera (PV) and in 55% of myelofibrosis (MF) patients, opened the way for a new era of targeted therapies for myeloproliferative neoplasms. Ruxolitinib was the first-i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(16)30143-6

    authors: Soret J,Kiladjian JJ

    更新日期:2016-06-01 00:00:00

  • [DNA mismatch repair and BRAF status in colorectal cancer: Interest for the therapeutic management?].

    abstract::Colorectal cancer (CRC) is the second leading cause of cancer-related mortality in France. Recently, colorectal cancer subtyping consortium (CRCSC) identified 4 consensus molecular subtypes (CMS). CMS1 is enriched for CRC with deficient DNA mismatch repair system (dMMR) and tumors with mutated BRAF. Intriguingly, CMS1...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(15)31220-0

    authors: Cohen R,Cervera P,Svrcek M,Dumont C,Garcia ML,Chibaudel B,de Gramont A,Pocard M,Duval A,Fléjou JF,André T

    更新日期:2015-06-01 00:00:00

  • [Conservative management of malignant and borderline ovarian tumor].

    abstract::Conservative management of at least a part of one ovary and the uterus, in order to preserve fertility-potential, could be propose in most of patients with nonepithelial and borderline ovarian tumor. This conservative management could be performed even in patients with borderline ovarian tumor associated with noninvas...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Morice P,Camatte S,Wickart-Poque F,Rouzier R,Pautier P,Pomel C,Lhommé C,Haie-Meder C,Duvillard P,Castaigne D

    更新日期:2002-12-01 00:00:00

  • [Suicidal crisis in oncology: assessment and care].

    abstract::Patients with advanced cancer often experience with physical impairment and loss of autonomy sometimes preceding inexorable death. It is that can emerge Suicidal ideation occasionally associated with suicidal attempt can arise in this particular context but also following the initial diagnostic talk and during all the...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lefetz C,Reich M

    更新日期:2006-07-01 00:00:00

  • [Surgery after chemotherapy: gastric cancer].

    abstract::Perioperative chemotherapy for gastric cancer is validated by two phase III studies. The impact of the preoperative neoadjuvant sequence is probably major in the benefit of this treatment. This chemotherapy increases the R0 resection without increasing either morbidity or mortality. Furthermore, it reduces local and s...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1287

    authors: Flamein R,Antomarchi O,Pezet D

    更新日期:2011-01-01 00:00:00

  • 4-methylthio 2-oxobutanoate transaminase: a specific target for antiproliferative agents.

    abstract::We have previously shown that the addition of 4-methylthio-2-oxobutanoate (MTOB) to cultures of methionine dependent neoplastic cells which lack endogenous MTOB restores their capacity to grow in the absence of exogenous methionine. Transition state inhibitors of the MTOB transaminase,responsible for the transaminatio...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Quash G,Roch AM,Charlot C,Chantepie J,Thomas V,Hamedi-Sangsari F,Vila J

    更新日期:2004-04-01 00:00:00

  • [Gemcitabine and breast cancer].

    abstract::Gemcitabine has demonstrated a good efficacy in number of tumor types. Thanks to its favourable toxicity profile, gemcitabine can be used in combination with a number of drugs. Single agent gemcitabine and gemcitabine-based combinations have been evaluated in metastatic breast cancer. Some of these combinations, such ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Besse B,Spano JP

    更新日期:2002-08-01 00:00:00

  • [Treatment of mucositis pain: News and prospects].

    abstract::Mucositis, an acute inflammation of the digestive mucosa, is one of the main toxicities secondary to oncological treatments. Among its consequences, mucositis-related pain is an important complication due to its intensity and repercussion, especially on quality of life. Treatment of pain plays a central role in manage...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2019.03.022

    authors: Guerrini-Rousseau L,Marec-Berard P,Bolle S,Laurent S

    更新日期:2019-09-01 00:00:00

  • Traitement par cellules CAR-T : état des lieux de leur utilisation aux États-Unis en 2018.

    abstract:CAR-T THERAPY:CURRENT USE IN THE UNITED STATES IN 2018: Treatment with T-cells engineered with chimeric antigen receptors (CAR T-cell therapy) has been a field of intense research in the United States since the 1980s. The recent approval in August 2017 of Kymriah (tisagenlecleucel) opened the door to broader access to ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(19)30052-9

    authors: Gauthier J

    更新日期:2018-12-01 00:00:00

  • [Secondary non-Hodgkin's lymphomas].

    abstract::Developing a secondary non Hodgkin's lymphoma (NHL) more than 12 months after treatment for first cancer, is uncommon. Secondary NHL occurs sometimes after chronic lymphatic leukemia or Hodgkin's disease. The 20 years cumulative incidence rate is 3-5% after Hodgkin's disease. Secondary NHL seems less frequent after an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Cappelaere P

    更新日期:1998-03-01 00:00:00

  • [Patients' information in percutaneous core breast biopsy].

    abstract::Information takes a large part of patient's perceptions of the procedure. If the information is adapted, patients tolerate the procedure well. We point out indications and explain the different types of procedure. For infraclinical masses, sonographically guided automated core needle biopsy removes samples. Sonographi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Barreau B,Tastet S,Lakdja F,Henriquès C,Valentin F,Labat MJ,Dilhuydy MH

    更新日期:2005-03-01 00:00:00

  • [Breast cancer management before 40 years: what change in one decade? A retrospective study at the "Institut de cancérologie de Lorraine": 2002-2012].

    abstract:INTRODUCTION:Breast cancer of young women has medico-psychological issues, particularly in the perspective of "after cancer" period. The objective of the study was to analyze the changes in management, in a decade including the publication of Cancer Plans I and II. METHODS:This retrospective unicentric study involved ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(20)30049-7

    authors: Soussoko M,Salleron J,Desandes E,Lesur A

    更新日期:2019-12-01 00:00:00

  • [Limitations of palliative chemotherapy, application to lung cancer: the point of view of hospital pharmacists].

    abstract::In our hospital, most of the patients with a cancer received palliative chemotherapy. Then, we wanted to know in which conditions these therapies were realised and most specially for patients with lung cancer. We noted the stage of the disease at the diagnosis, the median survival duration after diagnosis and the medi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Demange C,Thiébaux I

    更新日期:2003-03-01 00:00:00

  • [Study of mdm2 gene amplification in primary breast tumors].

    abstract::mdm2 (mouse double minute) protein seems lead to p53 inactivation and therefore might potentially play a role in carcinogenesis. We have studied mdm2 gene amplification from 239 primary breast cancer tissues. mdm2 gene was amplified in 10% of cases (25/239). mdm2 amplification was associated with c-erbB2 amplification...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Fontana X,Ferrari P,Abbes M,Monticelli J,Namer M,Bussière F

    更新日期:1994-07-01 00:00:00

  • [Adaptation and validation of a brief screening questionnaire of depressive disorders in patients with cancer: Q2i study].

    abstract:BACKGROUND:Depression is a sustainable state of deep sadness and abatement. It is frequently identified in patients with cancer and often undervalued by oncologists. The reduced PRIME-MD questionnaire is a questionnaire of 2 items validated in French. However, it has been neither translated nor validated in French. The...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2015.09.008

    authors: Barriere J,Mari V,Cherikh F,Largillier R,Ettaiche M,Schiappa R,Chamorey E,Ferrero JM,Gal J

    更新日期:2016-02-01 00:00:00

  • [The impact of gynaecological cancers on woman's sexuality and her couple].

    abstract::This article, devoted specifically to gynaecological cancers and their impact on the sexual and marital lives, is a collaboration between the psychologists and onco-gynaecologist within a cancer center. In oncology, gynaecological cancers' treatments involve at the same time anatomical, physiological and functional mo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.02.008

    authors: Vanlerenberghe E,Sedda AL,Ait-Kaci F

    更新日期:2015-05-01 00:00:00

  • First-line simplified GEMOX (S-GemOx) versus classical GEMOX in metastatic pancreatic cancer (MPA): results of a GERCOR randomized phase II study.

    abstract:PURPOSE:GemOx was defined as a D1-D2 schedule, based on preclinical data. In order to improve convenience for patients, we evaluated a simplified D1-D1 GemOx regimen (S-GemOx) in MPA. PATIENTS AND METHODS:Patients (pts) with MPA were 2:1 randomly assigned for first-line treatment to S-GemOx (gemcitabine 1,000 mg/m(2),...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1684/bdc.2009.0871

    authors: Afchain P,Chibaudel B,Lledo G,Selle F,Bengrine-Lefevre L,Nguyen S,Paitel JF,Mineur L,Artru P,André T,Louvet C

    更新日期:2009-05-01 00:00:00

  • [Particle therapy: carbon ions].

    abstract::Carbon ion therapy is an innovative radiation therapy. It has been first proposed in the forties by Robert Wilson, however the first dedicated centres for human care have been build up only recently in Japan and Germany. The interest of carbon ion is twofold: 1) the very sharp targeting of the tumour with the so calle...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1151

    authors: Pommier P,Hu Y,Baron MH,Chapet O,Balosso J

    更新日期:2010-07-01 00:00:00

  • On the value of response criteria in therapeutic research.

    abstract::Primary chemotherapy is the use of anticancer drugs as the first treatment in patients with localized tumor presentations for which there is an alternative but less than satisfactory treatment. Its most important feature is the preservation of the primary tumor mass as a biologic marker of response, and in this sense ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Devita VT Jr

    更新日期:1988-01-01 00:00:00

  • An interim assessment of the experience of fast neutron boost in inoperable rectal carcinomas in Orléans.

    abstract::Since January 1981, 58 patients with postoperative recurrences or inoperable rectal cancer have been included in a trial featuring a neutron boost after an initial series of irradiation given by the classical high energy photon procedure. This group irradiated at the Neutrontherapy Unit in Orléans was compared to a hi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Breteau N,Destembert B,Favre A,Sabattier R,Schlienger M

    更新日期:1986-01-01 00:00:00

  • [Value of thymidine kinase in the prediction of response to treatment by chemotherapy or hormone therapy in breast cancer].

    abstract::Thymidine kinase (TK) was assayed in the cytosol of 210 primary breast cancers to assess its predictive value for response to first line chemotherapy and hormonotherapy. We performed correlations between TK and the other prognosis factors of breast cancer. TK activity is correlated with SBR grading and estrogen recept...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bennini N,Mauriac L,Wafflart J,Bonichon F,Durand M

    更新日期:1992-01-01 00:00:00

  • [Current views in geriatric oncology].

    abstract::Geriatric oncology represents a novel specialty which can be defined as specific older cancer patients management. It includes a validated geriatric procedure, the comprehensive geriatric assessment, which is the best way of approaching the complex interacting medical problems of frail older patients. Geriatric assess...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Terret C,Gaujard S,Droz JP

    更新日期:2003-01-01 00:00:00

  • [Infiltrating carcinoma of the uterine cervix: epidemiology, prognostic factors, therapeutic strategies].

    abstract::In industrialized countries cervical cancer has decreased over the past decades. This, thanks to wide spread screening campaigns of precancerous lesions and microinvasive diseases through regular pap smears starting from the beginning of sexual activity. The diagnostic is realized earlier, thus increasing the rate of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Pereira R,Renard A,Boulbair F,Touboul E,Lefranc JP

    更新日期:1998-11-01 00:00:00

  • [Urothelial tumors in children].

    abstract::Urothelial tumors are very rare in children (to date, only about 150 cases have been reported worlwide). Only 20% occur before the age of ten. The aim of this study is to specify the clinicopathologic features of urothelial tumor in young patients, which require a slightly different approach to treatment. On the basis...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.11.018

    authors: Grapin-Dagorno C,Peycelon M,Philippe-Chomette P,Berrebi D,El Ghoneimi A,Orbach D

    更新日期:2017-02-01 00:00:00

  • Chemoresistance in the clinic: overview 1994.

    abstract::One of the most exciting areas in clinical oncology today is the translation of laboratory research in drug resistance into therapeutic tools to improve responses to antineoplastic drugs. Two areas of investigation are currently under study in both the laboratory and clinic: reversal of gluthathione-mediated resistanc...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,评审

    doi:

    authors: Bates SE,Regis JI,Robey RW,Zhan Z,Scala S,Meadows BJ

    更新日期:1994-12-01 00:00:00

  • [Nab-paclitaxel].

    abstract::Paclitaxel is conventionally used in a wide range of oncology indications. Nab-paclitaxel is synthesized by a process of high pressure homogenization of paclitaxel in the presence of human albumin and it was originally developed to reduce the toxicity usually associated with cremophor in soluble paclitaxel and to incr...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.03.020

    authors: Lopez-Trabada Ataz D,Dumont S,André T

    更新日期:2015-06-01 00:00:00